These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6491948)

  • 1. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
    Garfinkel D; Mamelok RD; Blaschke TF
    Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallopamil binding to human serum proteins.
    Rutledge DR; Pieper JA
    Eur J Clin Pharmacol; 1987; 33(4):375-80. PubMed ID: 3443143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL; Slaughter RL; Edwards DJ; Lalka D
    Eur J Clin Pharmacol; 1983; 25(3):413-7. PubMed ID: 6628530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.
    Kates RE; Sokoloski TD; Comstock TJ
    Clin Pharmacol Ther; 1978 Jan; 23(1):30-5. PubMed ID: 618708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting in vitro protein binding of etoposide in humans.
    Fleming RA; Evans WE; Arbuck SG; Stewart CF
    J Pharm Sci; 1992 Mar; 81(3):259-64. PubMed ID: 1640365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro protein binding of propafenone in normal and uraemic human sera.
    Chan GL; Axelson JE; Price JD; McErlane KM; Kerr CR
    Eur J Clin Pharmacol; 1989; 36(5):495-9. PubMed ID: 2753068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma binding of quinidine after surgery: a preliminary report.
    Fremstad D; Bergerud K; Haffner JF; Lunde PK
    Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal quinidine binding in survivors of prehospital cardiac arrest.
    Kessler KM; Lisker B; Conde C; Silver J; Ho-Tung P; Hamburg C; Myerburg RJ
    Am Heart J; 1984 Apr; 107(4):665-9. PubMed ID: 6702560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma.
    Pike E; Skuterud B; Kierulf P; Fremstad D; Abdel Sayed SM; Lunde PK
    Clin Pharmacokinet; 1981; 6(5):367-74. PubMed ID: 7333058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic drug clearance following traumatic injury.
    Slaughter RL; Hassett JM
    Drug Intell Clin Pharm; 1985 Nov; 19(11):799-806. PubMed ID: 3905320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.